Top Markets
#1 Audiera Audiera +42.05%
#2 Tutorial Tutorial +36.83%
#3 Arowana Arowana +34.23%
#4 Fabric Protocol Fabric Protocol +30.69%
#5 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +29.88%
#6 Bitcoin Cash Bitcoin Cash +29.09%
#7 GALA GALA +26.96%
#8 Zora Zora +24.34%
#9 Ethena Staked ENA Ethena Staked ENA +24.08%
#10 aPriori aPriori +23.89%
Coin of the day
Audiera Audiera
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
Rang în acțiuni #24601
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Preț acțiune
$3.09
Capitalizare de piață
$58.82M
Schimbare (1 zi)
0.33%
Schimbare (1 an)
-73.01%
Țară
US
Tranzacționează Elicio Therapeutics, Inc. (ELTX)

Categorie

Healthcare
Raport P/B pentru Elicio Therapeutics, Inc. (ELTX)
Raport P/B la data de 2026 TTM: 0
Conform celor mai recente rapoarte financiare și prețului acțiunilor Elicio Therapeutics, Inc., raportul P/B actual (TTM) este 0. La sfârșitul anului 2026, compania avea un P/B de 0.
Istoricul raportului P/B pentru Elicio Therapeutics, Inc. din 2026 până în 2026
Raport P/B la sfârșitul fiecărui an
An Raport P/B Schimbă
Nu sunt suficiente date pentru perioada selectată.
Raport P/B pentru companii similare sau competitoare
Companie Raport P/B Diferență raport P/B Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH